Welcome to Ensem Theraputics
Kinetic Ensemble ®
for Precision Medicine
for Precision Medicine
Who We Are
ENSEM is a pioneering drug discovery and development company
that leverages its unique Kinetic Ensemble
® platform to develop innovative
small molecule precision medicines for oncology, with
potential to expand into genetic disorders and other disease
areas. ENSEM integrates computational and AI deep learning
methodologies with advanced experimental techniques to
identify non-obvious binding pockets and accelerate
structure-based drug design, with a focus on high-value
and difficult-to-drug targets.
Cryptic binding pockets: A small molecule (yellow) induces
protein conformational changes (blue) and the opening of a
cryptic pocket.
Our Mission is to expand the universe of druggable targets to
discover transformative therapies for PATIENTS
Expand The Universe of Druggable targets via AI-powered
Kinetic Ensemble ®
ENSEM develops and leverages Artificial Intelligence-powered
structural Kinetic Ensemble
® platform to discover cryptic
pockets of traditionally undruggable targets, offering new
opportunities for therapeutic intervention.
Dedicated to precision medicines
ENSEM leverages big data with advanced modeling and analytics
to pioneer breakthrough precision therapies for genetically
defined diseases, with Oncology as our initial focus.
We are owners driven to innovate and blaze new trails with
urgency. We are bold in scope and optimistic in spirit. We
embrace challenges with tenacity and hope.
We pursue our mission with passion and unwavering resolve.
We make strategic choices and move forward with the best
ideas to discover transformative medicines.
We do what’s right for our patients. We follow the science
and act with integrity, care & humility. We are disciplined
and rigorous; empowered and accountable for our actions.
We are a high performing, diverse and inclusive team. We
build open and honest relationships. We speak our mind and
make it safe for others to do so.